Log in

NYSE:EHCEncompass Health Stock Price, Forecast & News

$61.30
+1.01 (+1.68 %)
(As of 07/10/2020 04:00 PM ET)
Add
Compare
Today's Range
$59.80
Now: $61.30
$61.52
50-Day Range
$59.31
MA: $67.47
$74.97
52-Week Range
$48.01
Now: $61.30
$83.30
Volume466,500 shs
Average Volume809,608 shs
Market Capitalization$6.09 billion
P/E Ratio17.77
Dividend Yield1.83%
Beta0.88
Encompass Health Corporation provides facility-based and home-based post-acute healthcare services in the United States. The company operates through two segments, Inpatient Rehabilitation, and Home Health and Hospice. The Inpatient Rehabilitation segment provides specialized rehabilitative treatment on an inpatient and outpatient basis to patients who are recovering from conditions, such as stroke and other neurological disorders, cardiac and pulmonary conditions, brain and spinal cord injuries, complex orthopedic conditions, and amputations. The Home Health and Hospice segment provides home health and hospice services primarily in the Southeast and Texas. Its home health services include a range of Medicare-certified home nursing services to adult patients in need of care comprising skilled nursing, medical social work, and home health aide services, as well as physical, occupational, speech therapy, and others. This segment's hospice services comprise in-home services to terminally ill patients and their families to address patients' physical needs, including pain control and symptom management, and to provide emotional and spiritual support. As of February 21, 2019, Encompass Health Corporation operated 130 hospitals, and 278 home health and hospice agencies in 36 states and Puerto Rico. The company was formerly known as HealthSouth Corporation and changed its name to Encompass Health Corporation in January 2018. Encompass Health Corporation was founded in 1983 and is based in Birmingham, Alabama.
Read More
Encompass Health logo

Beat the Market (BTM) Rank

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 3.3Insider Behavior: 1.0Valuation: 1.9 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

2.47 out of 5 stars


Industry, Sector and Symbol

Industry Hospitals
Sub-IndustryN/A
SectorMedical
CUSIPN/A
CIKN/A
Phone205-967-7116

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$4.61 billion
Cash Flow$6.22 per share
Book Value$17.17 per share

Profitability

Net Income$358.70 million

Miscellaneous

Employees31,570
Market Cap$6.09 billion
Next Earnings DateN/A
OptionableOptionable

Receive EHC News and Ratings via Email

Sign-up to receive the latest news and ratings for EHC and its competitors with MarketBeat's FREE daily newsletter.

Encompass Health (NYSE:EHC) Frequently Asked Questions

How has Encompass Health's stock been impacted by COVID-19 (Coronavirus)?

Encompass Health's stock was trading at $63.85 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, EHC shares have decreased by 4.0% and is now trading at $61.30. View which stocks have been most impacted by Coronavirus.

Do Wall Street analysts recommend investors buy shares of Encompass Health?

10 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Encompass Health in the last year. There are currently 1 hold rating and 9 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View analyst ratings for Encompass Health.

How were Encompass Health's earnings last quarter?

Encompass Health Corp (NYSE:EHC) announced its quarterly earnings data on Tuesday, April, 28th. The company reported $0.87 EPS for the quarter, meeting the Thomson Reuters' consensus estimate of $0.87. The firm had revenue of $1.18 billion for the quarter, compared to the consensus estimate of $1.20 billion. Encompass Health had a net margin of 7.36% and a return on equity of 22.00%. View Encompass Health's earnings history.

How often does Encompass Health pay dividends? What is the dividend yield for Encompass Health?

Encompass Health announced a quarterly dividend on Wednesday, May 6th. Investors of record on Wednesday, July 1st will be given a dividend of $0.28 per share on Wednesday, July 15th. This represents a $1.12 dividend on an annualized basis and a yield of 1.83%. The ex-dividend date of this dividend is Tuesday, June 30th. View Encompass Health's dividend history.

What price target have analysts set for EHC?

10 brokerages have issued 1-year price objectives for Encompass Health's stock. Their forecasts range from $83.00 to $100.00. On average, they anticipate Encompass Health's share price to reach $91.78 in the next twelve months. This suggests a possible upside of 49.7% from the stock's current price. View analysts' price targets for Encompass Health.

Has Encompass Health been receiving favorable news coverage?

News articles about EHC stock have been trending neutral recently, InfoTrie Sentiment reports. The research firm identifies positive and negative media coverage by analyzing more than six thousand news and blog sources. The firm ranks coverage of companies on a scale of -5 to 5, with scores closest to five being the most favorable. Encompass Health earned a media sentiment score of 0.4 on InfoTrie's scale. They also assigned news headlines about the company a news buzz of 0.0 out of 10, indicating that recent media coverage is extremely unlikely to have an effect on the company's share price in the next few days. View the latest news about Encompass Health.

Are investors shorting Encompass Health?

Encompass Health saw a decline in short interest in June. As of June 30th, there was short interest totaling 1,810,000 shares, a decline of 18.5% from the June 15th total of 2,220,000 shares. Based on an average trading volume of 766,000 shares, the days-to-cover ratio is currently 2.4 days. Approximately 1.9% of the shares of the company are short sold. View Encompass Health's Current Options Chain.

Who are some of Encompass Health's key competitors?

What other stocks do shareholders of Encompass Health own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Encompass Health investors own include Adobe (ADBE), salesforce.com (CRM), Palo Alto Networks (PANW), Alibaba Group (BABA), Netflix (NFLX), Edwards Lifesciences (EW), Johnson & Johnson (JNJ), Vertex Pharmaceuticals (VRTX), Advanced Micro Devices (AMD) and NVIDIA (NVDA).

Who are Encompass Health's key executives?

Encompass Health's management team includes the following people:
  • Mr. Mark J. Tarr, CEO, Pres & Director (Age 57)
  • Mr. Douglas E. Coltharp, Exec. VP & CFO (Age 57)
  • Mr. John Patrick Darby, Exec. VP, Gen. Counsel & Corp. Sec. (Age 54)
  • Ms. Barbara Ann Jacobsmeyer, Exec. VP & Pres Inpatient Hospitals (Age 53)
  • Mr. Andrew L. Price, Sr. VP & Chief Accounting Officer (Age 52)

What is Encompass Health's stock symbol?

Encompass Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "EHC."

How do I buy shares of Encompass Health?

Shares of EHC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Encompass Health's stock price today?

One share of EHC stock can currently be purchased for approximately $61.30.

How big of a company is Encompass Health?

Encompass Health has a market capitalization of $6.09 billion and generates $4.61 billion in revenue each year. The company earns $358.70 million in net income (profit) each year or $3.91 on an earnings per share basis. Encompass Health employs 31,570 workers across the globe.

What is Encompass Health's official website?

The official website for Encompass Health is www.encompasshealth.com.

How can I contact Encompass Health?

Encompass Health's mailing address is 9001 LIBERTY PARKWAY, BIRMINGHAM AL, 35242. The company can be reached via phone at 205-967-7116 or via email at [email protected]

This page was last updated on 7/12/2020 by MarketBeat.com Staff

30 Days of MarketBeat All Access for $1.00

Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools:

  • Best-in-Class Portfolio Monitoring

    View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.

  • Stock Ideas and Recommendations

    Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.

  • Advanced Stock Screeners and Research Tools

    Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.